NRX Pharmaceuticals, Inc. Common Stock

NRXPNASDAQ • USD
2.33 USD
↗ 0.18 (8.14%)🟢LIVE (AS OF 02:15 PM EST)
🟢Market: OPEN

NRX Pharmaceuticals, Inc. Common Stock (NRXP) is currently trading at $2.33. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (13811.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$2.15
High?$2.46
Low?$2.10
Prev. Close?$2.15
Volume?1.0M
Avg. Volume?1.4M
VWAP?$2.32
Rel. Volume?0.75x
Bid / Ask
Bid?$2.28 × 100
Ask?$2.30 × 200
Spread?$0.02
Midpoint?$2.29
Valuation & Ratios
Market Cap?93.8M
Shares Out?43.6M
Float?34.0M
Float %?93.9%
P/E Ratio?N/A
P/B Ratio?-552.00
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Employees
29
Market Cap
93.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-05-25
Address
1201 ORANGE STREET
WILMINGTON, DE 19801
Phone: 484-254-6134
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
60
Short Sent.?
18
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.66Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?30.76%Squeeze Risk
Short Interest?10.5M
Days to Cover?4.6
Free Float34.0M
Avg Daily Volume2.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?0.86Weak
Quick Ratio?0.86Weak
Cash Ratio?0.79Adequate
Debt/Equity?-2.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-552.00CHEAP▾
P/S?
Peers
100
S&P
3
27.65HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
19.91HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
13,811.8%STRONG▾
ROA?
S&P
3
-68.7%WEAK▾
Cash Flow & Enterprise
FCF?$-20671000
Enterprise Value?$67.6M
Fundamentals ratios updated end of day